Quarterly earnings trajectoryCore earnings versus plan; USD millions2025–2026Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26EQ4'26EBlue: actual / forecast Green: plan
Earnings versus planYTD attribution; USD millions+$83m974Plan+41Assets+18Claims+27Expense−16Other1,057Actual
Business-line performanceYTD earnings, ROE and value creationEnterpriseSegmentCore earningsvs. planROEPVDE emergenceIndividual life$284m+$17m16.7%$108mAnnuities$316m+$28m19.5%$134mGroup benefits$172m−$6m14.8%$61mWealth / asset management$125m+$13m22.1%$72mCorporate / other$61m+$9m—$37m
Investment performanceYield and income measuresAbove planPortfolio yield6.08%+19 bps vs. planTotal return6.41%+46 bps vs. currentCredit losses$43m$8m below planPrivate credit yield8.10%+60 bps vs. current
Operating performanceKey efficiency measuresYTDExpense plan97%Claims efficiency104%New business target101%Retention target98%Capital deployment93%
Management action value captureRealized and forecast benefit against approved business case$167m run rateActionApproved benefitYTD realizedRun-rate forecastStatusStrategic asset allocation$74m$36m$78mAheadALM repositioning$31m$12m$29mOn trackReinsurance program$24m$7m$22mOn trackHedging overlay$18m$4m$21mAheadExpense efficiency$20m$9m$17mWatch
Forecast confidenceFull-year outcome rangesStableNet incomeHighCore earningsHighInvestment incomeMed.Claims experienceMed.Capital ratioHigh